Skip to main content
Clinical Trials/PACTR202407847952117
PACTR202407847952117Not yet recruitingPhase 1

Comparative evaluation of occlusal-splint and drug treatments in the management of temporomandibular disorders in a Northern Nigerian population

Self funded0 sites60 target enrollmentStarted: July 20, 2024Last updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 Year(s) to 44 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Potential participant must be at least 18 years old
  • 2.Must have active symptoms at presentation
  • 3.Must not have received any treatment for TMD in the past 2 months
  • 4.Must be at least partially dentate with grossly stable occlusion of posterior teeth
  • 5.Must not have radiographic evidence of occlusal trauma or derangement

Exclusion Criteria

  • 1.Edentulous individuals
  • 2.Individuals who wear partial dentures to obtain occlusion of posterior teeth
  • 3.Individuals who have been treated for TMD within 2 months prior to presentation
  • 4.Individuals who regularly take medication that may interfere with results e.g. painkillers, tranquilizers and muscle relaxants.
  • 5.Individuals with radiographic evidence of occlusal trauma or derangement

Investigators

Sponsor
Self funded

Similar Trials